MAF and breast carcinoma: Conversely, 16q23 gain or c-Maf overexpression promotes breast cancer bone metastasis, a process that may be mediated by downregulation of the c-Maf target gene PTHrP, a crucial predictor for bone relapse in advanced breast tumors [118, 156].